HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study

Prospective Cohort ◽

Real Life ◽

Direct Acting Antiviral ◽

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

The Lancet ◽

10.1016/s0140-6736(18)32111-1 ◽

2019 ◽

Vol 393 (10179) ◽

pp. 1453-1464 ◽

Cited By ~ 138

Author(s):

Fabrice Carrat ◽

Hélène Fontaine ◽

Céline Dorival ◽

Mélanie Simony ◽

Alpha Diallo ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cohort Study ◽

Hepatitis C ◽

Clinical Outcomes ◽

Chronic Hepatitis C ◽

Prospective Cohort ◽

Antiviral Treatment ◽

Direct Acting Antiviral ◽

Predictors of Sustained Virological Response (SVR) in Patients with Advanced Chronic Hepatitis C (CHC) Treated with Current Direct Acting Antiviral(s) (DAA). Heraclis: Hellenic Multicenter Real-Life Cohort Study

Gastroenterology ◽

10.1016/s0016-5085(17)33683-1 ◽

2017 ◽

Vol 152 (5) ◽

pp. S1093 ◽

Cited By ~ 1

Author(s):

George Papatheodoridis ◽

Spilios Manolakopoulos ◽

Andreas Kapatais ◽

Emanuel Sinakos ◽

Ioannis Elefsiniotis ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cohort Study ◽

Hepatitis C ◽

Sustained Virological Response ◽

Chronic Hepatitis C ◽

Virological Response ◽

Real Life ◽

Direct Acting Antiviral ◽

Association of Chronic Hepatitis C Infection Related Depression, Anxiety, and Neurocognitive Performance Achieving SVR-12 with Direct-Acting Antivirals: A Prospective Cohort Study

SSRN Electronic Journal ◽

10.2139/ssrn.3946280 ◽

2021 ◽

Author(s):

Harmanpreet Kaur ◽

Radha K. Dhiman ◽

Anand V. Kulkarni ◽

Madhumita Premkumar ◽

Virendra Singh ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cohort Study ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Prospective Cohort ◽

Direct Acting Antivirals ◽

Neurocognitive Performance ◽

Hepatitis C Infection ◽

Platelets represent an independent predictor of sustained virological response (SVR) in patients with advanced chronic hepatitis C (CHC) treated with current direct acting antiviral(s) (DAA). HERACLIS: Hellenic multicenter real-life cohort study

Journal of Hepatology ◽

10.1016/s0168-8278(17)31403-4 ◽

2017 ◽

Vol 66 (1) ◽

pp. S502

Author(s):

G. Papatheodoridis ◽

A. Kapatais ◽

E. Sinakos ◽

I. Elefsiniotis ◽

J. Goulis ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cohort Study ◽

Hepatitis C ◽

Sustained Virological Response ◽

Chronic Hepatitis C ◽

Virological Response ◽

Independent Predictor ◽

Real Life ◽

Direct Acting Antiviral ◽

Direct-acting Antiviral Agents in Patients with Chronic Hepatitis C: Real-life Data

Viral Hepatitis Journal ◽

10.4274/vhd.galenos.2021.2020-11-1 ◽

2021 ◽

Vol 27 (2) ◽

pp. 42-48

Author(s):

Ayhan Balkan ◽

Yasemin Balkan ◽

Abdullah Emre Yıldırım ◽

Buğra Tolga Konduk ◽

Sezgin Barutçu ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Antiviral Agents ◽

Real Life ◽

Direct Acting Antiviral ◽

Life Data ◽

Real Life Data ◽

Direct Acting ◽

Direct Acting Antiviral Agents

Direct‐acting antiviral agents in the treatment of chronic hepatitis C—Real‐life experience from clinical practices in Pakistan

Journal of Medical Virology ◽

10.1002/jmv.25745 ◽

2020 ◽

Vol 92 (12) ◽

pp. 3475-3487 ◽

Cited By ~ 1

Author(s):

Saima Mushtaq ◽

Atika Mansoor ◽

Muhammad Umar ◽

Amjad Khan ◽

Saima Siddiqi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Life Experience ◽

Antiviral Agents ◽

Real Life ◽

Clinical Practices ◽

Direct Acting Antiviral ◽

Direct Acting ◽

Direct Acting Antiviral Agents

Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C

Journal of Viral Hepatitis ◽

10.1111/j.1365-2893.2010.01310.x ◽

2011 ◽

Vol 18 (5) ◽

pp. 331-337 ◽

Cited By ~ 17

Author(s):

K. Patel ◽

R. Jhaveri ◽

J. George ◽

G. Qiang ◽

C. Kenedi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cohort Study ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Prospective Cohort ◽

Open Label ◽

Antiviral Efficacy ◽

Lipid Fractions

Safety of oral direct acting antiviral regimens for chronic hepatitis C in real life conditions

Postgraduate Medicine ◽

10.1080/00325481.2017.1311197 ◽

2017 ◽

Vol 129 (4) ◽

pp. 476-483 ◽

Cited By ~ 11

Author(s):

Regina Juanbeltz ◽

Silvia Goñi Esarte ◽

Juan Isidro Úriz-Otano ◽

Ana Martínez Echeverría ◽

Inmaculada Elizalde ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real Life ◽

Direct Acting Antiviral ◽

Life Conditions ◽

Characteristics of Chronic Hepatitis C Patients who Discontinued the Current Direct Acting Antiviral Therapy in Real Life

The American Journal of Gastroenterology ◽

10.14309/00000434-201310001-00538 ◽

2013 ◽

Vol 108 ◽

pp. S158

Author(s):

Omar Mousa ◽

Ly-Elaine Pham ◽

Chukwuma Egwim ◽

Scott Zela ◽

Victor Ankoma-Sey

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Antiviral Therapy ◽

Chronic Hepatitis C ◽

Real Life ◽

Direct Acting Antiviral ◽

Direct Acting ◽

Chronic Hepatitis C Patients

Direct acting antiviral-based treatment of hepatitis C virus infection among people who inject drugs in Georgia: A prospective cohort study

International Journal of Drug Policy ◽

10.1016/j.drugpo.2018.07.016 ◽

2018 ◽

Vol 62 ◽

pp. 104-111 ◽

Cited By ~ 2

Author(s):

Julie Bouscaillou ◽

Tamar Kikvidze ◽

Maia Butsashvili ◽

Konstantine Labartkava ◽

Ina Inaridze ◽

...

Keyword(s):

Cohort Study ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Virus Infection ◽

Prospective Cohort ◽

People Who Inject Drugs ◽

Hepatitis C Virus Infection ◽

Direct Acting Antiviral ◽